medigraphic.com
Archivos de Medicina (Manizales)

2022, Number 1

<< Back Next >>

Arch Med 2022; 22 (1)

Prevalence of HIV in transgender people attended in an institution provider health services from Medellín-Colombia

Higuita GLF, Cardona AJA, Correa RK

Language: Spanish
References: 23
Page: 37-45
PDF size: 199.93 Kb.


ABSTRACT

Introduction: there are few studies of HIV prevalence in trans people in Colombia. Objective: to determine the prevalence of HIV in trans people treated in a health service provider institution in Medellín-Colombia. Methods: cross-sectional study with 87 people screened for HIV at the Fundación Antioqueña de Infectología. The diagnosis of HIV was made by immunochromatography confirmed by Western blot. A survey was conducted with sociodemographic data, clinical characteristics and sexual risk factors. HIV prevalence was calculated. Analyzes were done in SPSS 27.0. Results: HIV prevalence was 2.3%, without finding co-infection with other STIs (laboratory detection of viral hepatitis B and C, and Treponema pallidum). The largest proportion of the group were young, with little schooling and without health affiliation or subsidized regime. A high prevalence of risky sexual practices was found in the last month, such as unprotected sex (94.3%), with key groups (35.5%), under the effect of hallucinogens (26.4%) and with a new sexual partner (25.3%). Conclusion: HIV prevalence was much lower than in previous studies, although with a high proportion of sexual risk practices. This demonstrates the importance of carrying out more studies that show the panorama of infection in trans people and the need to improve specific education and prevention programs for this group|historically neglected.


REFERENCES

  1. Organización Mundial de la Salud. Temas de salud. VIH/SIDA. [Internet]. 2021. [consultado Mayo 20 de 2021]Disponible en: https://www.who.int/topics/hiv_aids/es/#

  2. Organización Mundial de la Salud. VIH/sida. Datos y cifras. [Internet]. 2020 nov. 30. [consultado Mayo 20 de2021] Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids

  3. ONUSIDA. Hoja informativa — Últimas estadísticas sobre el estado de la epidemia de sida. [Internet]. 2020.[consultado Agosto 19 de 2021] Disponible en: https://www.unaids.org/es/resources/fact-sheet.

  4. Cuenta de Alto Costo. VIH Sida en Colombia, retos y apuestas en salud [Internet]. Bogotá; 2020 nov. 30.[consultado Mayo 20 de 2021] Disponible en: https://cuentadealtocosto.org/site/vih/vih-sida-en-colombia-retos-yapuestas-en-salud/#:~:text=En Colombia%2C los casos reportados,36%25 por cada 100.000 habitantes.

  5. ONUSIDA. [Internet]. Grupos de población clave. [consultado Mayo 20 de 2021]Disponible en: https://www.unaids.org/es/topic/key-populations

  6. Organización Panamericana de la Salud. [Internet]. 2019. VIH/SIDA [consultado Mayo 20 de 2021] Disponibleen:https://www3.paho.org/hq/index.php?option=com_content&view=article&id=9573:2019-factsheet-hivaids&Itemid=40721&lang=es

  7. Yan H, Xiao W, Chen Y, Chen Y, Lin J, Yan Z, et al. High HIV prevalence and associated risk factors amongtransgender women in China: a cross-sectional survey. J Int AIDS Soc. 2019;22(11). DOI: 10.1002/jia2.25417

  8. Vi VTT, Long KQ, Hong LHTC, Anh HTN, Ngoc NV, Tam V Van, et al. HIV Prevalence and Factors Related toHIV Infection Among Transgender Women in Vietnam: A Respondent Driven Sampling Approach. AIDSBehav. 2020;24(11):3132–3141. Doi 10.1007/s10461-020-02867-5.

  9. Chhim S, Ngin C, Chhoun P, Tuot S, Ly C, Mun P, et al. HIV prevalence and factors associated with HIVinfection among transgender women in Cambodia: Results from a national Integrated Biological andBehavioral Survey. BMJ Open. 2017;7(8):1–12. DOI: http://dx.doi.org/10.1136/bmjopen-2016-015390

  10. Colby D, Nguyen NA, Le B, Toan T, Thien DD, Huyen HT, et al. HIV and Syphilis Prevalence Among TransgenderWomen in Ho Chi Minh City, Vietnam. AIDS Behav. 2016;20(3):379–85.DOI: https://doi.org/10.1007/s10461-016-1485-8

  11. Moayedi-Nia S, Taheri L, Hosseini Rouzbahani N, Rasoolinejad M, Nikzad R, Eftekhar Ardebili M, et al. HIV Prevalenceand Sexual Behaviors Among Transgender Women in Tehran, Iran. AIDS Behav. 2019;23(6):1590–1593.DOI: 10.1007/s10461-018-02380-w.

  12. Salas-Espinoza KJ, Menchaca-Diaz R, Patterson TL, Urada LA, Smith D, Strathdee SA, Pitpitan EV. HIV Prevalenceand Risk Behaviors in Male to Female (MTF) Transgender Persons in Tijuana, Mexico. AIDS Behav.2017 ;21(12):3271-3278. DOI: 10.1007/s10461-017-1931-2

  13. Ministerio de Salud y Protección Social. Estudio de vulnerabilidad al VIH y prevalencia de VIH en mujerestrans en Colombia 2016. [Internet]. 2016 Colombia; 2016. [consultado Mayo 20 de 2021]. Disponible en:https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/INTOR/libro-vulnerabilidad-mujeres-trasns.pdf

  14. Zea MC, Reisen CA, Del Río-González AM, Bianchi FT, Ramirez-Valles J, Poppen PJ. HIV prevalence andawareness of positive serostatus among men who have sex with men and transgender women in Bogotá,Colombia. Am J Public Health. 2015;105(8):1588–1595. DOI:10.2105/AJPH.2014.302307

  15. Cardona-Arias JA, Correa JCC, Higuita-Gutiérrez LF. Hiv prevalence and associated factors in key groupsand general population treated at a health care institution in colombia in 2019: A cross-sectional study.HIV/AIDS - Res Palliat Care. 2020; 12:381–391. DOI: 10.2147/HIV.S259792

  16. Wilson EC, Dhakal M, Sharma S, Rai A, Lama R, Chettri S, et al. Population-based HIV prevalence, stigmaand HIV risk among trans women in Nepal. BMC Infect Dis. 2021;21(1):1–9.DOI: https://doi.org/10.1186/s12879-021-05803-7

  17. Kirwan PD, Hibbert M, Kall M, Nambiar K, Ross M, Croxford S, et al. HIV prevalence and HIV clinical outcomesof transgender and gender-diverse people in England. HIV Med. 2021;22(2):131–139. DOI: 10.1111/hiv.12987

  18. Aguilar G, Samudio T, Lopez G, Jimenez L, Wilson EC, McFarland W, et al. High HIV prevalence among transgenderwomen in Paraguay. Int J STD AIDS. 2020;31(13):1308–1314. DOI: 10.1177/0956462420945550

  19. Kaplan RL, McGowan J, Wagner GJ. HIV prevalence and demographic determinants of condomless receptiveanal intercourse among trans feminine individuals in Beirut, Lebanon. J Int AIDS Soc. 2016;19(Suppl2):1–9. DOI:10.7448/IAS.19.3.20787

  20. Logie CH, Lacombe-Duncan A, Wang Y, Jones N, Levermore K, Neil A, et al. Prevalence and Correlates of HIVInfection and HIV Testing among Transgender Women in Jamaica. AIDS Patient Care STDS. 2016;30(9):416–24. DOI: 10.1089/apc.2016.0145

  21. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol. 2003; 1:25-34.DOI: https://doi.org/10.1038/nrmicro729

  22. Kulkarni PS, Butera ST, Duerr AC. Resistance to HIV-1 infection: lessons learned from studies of highlyexposed persistently seronegative (HEPS) individuals. AIDS Rev. 2003; 5:87–103.

  23. Buchacz K, Parekh B, Padian N, van der Straten A, Phillips S, Jonte J, et al. HIV-specific IgG in cervicovaginalsecretions of exposed HIV-uninfected female sexual partners of HIV-infected men. AIDS Res HumRetroviruses. 2001;17(18):1689-1693. DOI: 10.1089/08892220152741388




2020     |     www.medigraphic.com